A retrospective trial of abiraterone assessing abiraterone withdrawal syndrome (AWS) in patients with metastatic castration-resistant prostate cancer (mCRPC)
Latest Information Update: 31 Mar 2016
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Mar 2016 New trial record